Showing results (931-940 of 2,413) with videos related to

Sort By:
Pageof 242
Journal of Medical Economics|September 12, 2015
Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting β2-agonistsYaozhu J Chen, Charles Makin, Vamsi K Bollu, et al.
Journal of Medical Economics|October 30, 2015
Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspectiveStéphane Roze, Jayne Smith-Palmer, William J Valentine, et al.
Journal of Medical Economics|November 5, 2015
Febuxostat in the management of gout: a cost-effectiveness analysisLee J Smolen, James C Gahn, Ghaith Mitri, et al.
Journal of Medical Economics|January 30, 2016
Estimating healthcare resource use associated with the treatment of metastatic melanoma in eight countriesJan McKendrick, Merel Gijsen, Casey Quinn, et al.
Journal of Medical Economics|February 6, 2016
Cost of skeletal complications from bone metastases in six European countriesJ Pereira, J-J Body, O Gunther, et al.
Journal of Medical Economics|February 7, 2016
Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US populationJ Bradford Rice, Alan White, Andrea Lopez, et al.
Journal of Medical Economics|February 7, 2016
A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in CanadaC Beauchemin, N Letarte, K Mathurin, et al.
Journal of Medical Economics|February 25, 2016
MitraClip therapy in mitral regurgitation: a Markov model for the cost-effectiveness of a new therapeutic optionPatrice Guerin, Sandrine Bourguignon, Nicolas Jamet, et al.
Journal of Medical Economics|March 4, 2016
What happens after a single surgical intervention for hidradenitis suppurativa? A retrospective claims-based analysisGregor B E Jemec, Annie Guérin, Michael Kaminsky, et al.
Pageof 242